Passer au français
class members

Suboxone Tooth Decay Canadian Class Action

Investigation
Join This Class Action



CONSUMER LAW GROUP is investigating a Canada-wide class action lawsuit against Indivior, Aquestive Therapeutics, Monosol, Reckitt Benckiser and Pharma Importing for manufacturing and selling the prescription drug Suboxone to vulnerable Canadians, which they knew or should have known carries with it serious health concerns.

Suboxone combines the active ingredients buprenorphine and naloxone. Buprenorphine is highly acidic and, as recognized by the FDA and British Columbia’s Ministry of Health, its dissolution in a user’s mouth poses a serious risk of causing dental erosion, decay and infections.

Suboxone is only available in Canada by prescription and is used to treat opioid abuse disorder by reducing withdrawal symptoms and the urge to consume opioids, while avoiding the cyclical symptoms associated with opioid use.

Numerous published scientific studies concluded that dissolvable buprenorphine posed significant risks of causing tooth decay, erosion, infections, and cavities at a level comparable to the use of methamphetamines. Despite this scientific evidence, the drug companies failed to adequately disclose this risk to consumers.

If you or someone you know has ingested Suboxone and suffered dental injury and you wish to obtain more information on potential compensation or to be kept advised of the status of the Suboxone Tooth Decay Class Action litigation or any resulting compensation resulting from the Class Action Lawsuit in Canada, Ontario or Quebec, please provide your contact information to our law firm using the below form.

IF YOU WISH TO JOIN THE CLASS ACTION OR TO SIMPLY GET MORE INFORMATION, PLEASE COMPLETE THE FORM BELOW. Please note that providing your information creates no financial obligation for you. You are not charged any fee or cost for joining this class action. Our law firm is paid a contingency fee from the compensation recovered, only if the class action is successful. All information contained in this transmission is confidential and Consumer Law Group agrees to protect this information against unauthorized use, publication or disclosure.


Join This Class Action
 
Suboxone Tooth Decay Canadian Class Action
First Name:
Last Name:
Email:
Confirm Email:
Address:
City:
Province:
Country:
Postal Code:
Home phone:
Work phone:
Cell phone:
Fax:
Damages or Symptoms experienced:
Other Comments:
Please add my email address to the CLG.org mailing list to receive timely emails containing information on this class action and information on other CLG.org class actions. Information on class actions includes new class action announcements, relevant class action information updates, and class action payout information.

Disclaimer: The Consumer Law Group website is not intended to create an attorney-client relationship between you and the firm. By submitting your information to us, you are not creating an attorney-client relationship with the firm, although the information will be kept confidential. An attorney-client relationship may be formed only after we check for conflicts of interest and the firm and you sign a mandate agreement. The firm may contact you about your legal claim to discuss representation options. Because of the volume of e-mails, we cannot promise to respond to every submission.

In any class action lawsuit, it is the court that approves who will be eligible for participation in the class. If you feel you may qualify for damages or remedies that might be awarded in this class action litigation, we request you fill out the above form to help us determine if you are a legitimate member of the class or to make sure you get any court mailings about the case. However, the return of the above form does not guarantee you any type of compensation.


Enter the number above




Post a Comment

Time is of the essence for this program!
Canadian Vaccine Injury Compensation Program